LitAlert ~~ GeneLit.com

    • Etiologic Index - A Case-Only Measure of BRCA1/2-Associated Cancer Risk.
    • Hughley R, Karlic R, Joshi H, Turnbull C, Foulkes WD, Polak P.
    • N Engl J Med. 2020 Jul 16;383(3):286-288. doi: 10.1056/NEJMc1913988.
    • Letter
    • A Novel Mechanism to Induce BRCAness in Cancer Cells.
    • Cai C.
    • Cancer Res. 2020 Jul 15;80(14):2977-2978. doi: 10.1158/0008-5472.CAN-20-1451.
    • Commentary

    Original research:

    Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition.

    • A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.
    • Pishvaian MJ, Wang H, He AR, Hwang JJ, Smaglo BG, Kim SS, Weinberg BA, Weiner LM, Marshall JL, Brody JR.
    • Clin Cancer Res. 2020 Jul 15:clincanres.1301.2020. doi: 10.1158/1078-0432.CCR-20-1301. Epub ahead of print.
    • [A Case Report on the Effectiveness of Olaparib in a Patient with Recurrent Breast Cancer with Human Immunodeficiency Virus Infection].
    • Yabe S, Iwamoto N, Inokuchi T, Nara M, Saita C, Onishi M, Goto R, Yonekura R, Ishiba T, Honda Y, Miyamoto H, Aruga T.
    • Gan To Kagaku Ryoho. 2020 Jul;47(7):1089-1092. Japanese.
    • Case report. [Article in Japanese.]